Webcast is Live at 4:00 p.m. (CT)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Apr. 30, 2013--
SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface
modification and in vitro diagnostic technologies to the healthcare
industry, announced today that it will host a live webcast of its second
quarter 2013 conference call on Tuesday, May 7, at 4:00 p.m. CT (5:00
p.m. ET). The Company will issue an earnings news release after the
market closes that afternoon.
Gary Maharaj, chief executive officer, and Andy LaFrence, vice president
of finance and chief financial officer, will recap the second quarter
2013 financial results and accomplishments. To access the webcast, go to
the investor relations portion of the Company’s website at www.surmodics.com
the day of the conference call and click on the webcast icon.
An audio replay will be available beginning at 7:00 p.m. CT on Tuesday,
May 7, until 7:00 p.m. CT on Tuesday, May 14 and can be accessed by
dialing 800-406-7325 and entering conference call ID passcode 4613908.
In addition, the conference call audio and transcript will be archived
on the Company’s website following the call.
About SurModics, Inc.
SurModics’ mission is to exceed our
customers’ expectations and enhance patients’ well-being by providing
the world’s foremost, innovative surface modification technologies and in
vitro diagnostic chemical components. SurModics partners with the
world’s leading and emerging medical device, diagnostic and life science
companies to develop and commercialize innovative products designed to
improve patient diagnosis and treatment. Core offerings include surface
modification coating technologies that impart lubricity, prohealing, and
biocompatibility capabilities; and components for in vitro
diagnostic test kits and microarrays. SurModics is headquartered in Eden
Prairie, Minnesota. For more information about the Company, visit www.surmodics.com.
The content of SurModics’ website is not part of this press release or
part of any filings that the Company makes with the SEC.
Source: SurModics, Inc.
SurModics, Inc.
Andy LaFrence, 952-500-7000
ir@surmodics.com
